CAPIS Morning Note – 4/13/21: Johnson & Johnson Vaccine Pulled, Stocks Volatile
Morning Note
Morning Note
posted by CAPIS on 04/13/2021 at 7:34 am
by CAPIS on 04/13/2021
Breaking News: Johnson & Johnson (JNJ) vaccine for Covid-19 is pauses distribution of the vaccine due to blood clots in 6 women between age 16 and 48. Earnings Out After The Close Of Note: Beats: None Flat: None Misses: APHA (0.11) Capital Raises: IPOs Priced or News: New SPACs launched: Secondaries Priced: EPRT of note. Notes Priced of note: None of note. Common Stock filings: EPRT NI 0f note. Selling Shareholders of note: PAR FBIO of note. Private Placement of Public Entity (PIPE): Mixed Shelf Offerings: GNW GFL of note. Convertible Offering & Notes Filed: None of note. Note Offerings Filed: None of note. Capital Raise Summary From The TradeXchange ,bringing traders and investors real time news and Squawk Box, and other sources. News After The Close: Celldex Therapeutics (CLDX) announces promising data from its bispecific platform. Viper Energy Partners (VNOM) average production is now 15,500 bo/d. InterActive Corp (IAC) and its unit Angi (ANGI) report monthly metrics for March. Eldorado Gold (EGO) sees gold production for Q1 at 111,742 ounces. Various managers report asset levels AMK APAM CNS AB IVZ BEN Gilead Sciences (GILD) stops Phase 3 Remdesivir IV study in high risk non hospitalized with Covid-19. Lockheed Martin (LMT) wins $450 million Navy contract.…